|
|
Article: Appointments And Advancements.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Acorda Therapeutics, of Hawthorne, N.Y., appointed Lorin Randall to its board and chairman of the audit committee.
ActivBiotics Inc., of Lexington, Mass., appointed David McLachlan to its board.
Allos Therapeutics Inc., of Westminster, Colo., appointed Paul Berns president, CEO and member of its board.
Alpharma Inc., of Fort Lee, N.J., appointed Peter Tombros chairman.
Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Harry Penner to its board and audit committee.
Amarillo Biosciences Inc., of Amarillo, Texas, appointed Gary Coy chief financial officer.
Amarin Corp. plc, of London, appointed John Climax ...